網達軟件(603189.SH)取得一項發明專利證書
格隆匯 11 月 9日丨網達軟件(603189.SH)公佈,公司於近日收到了中華人民共和國國家知識產權局頒發的發明專利證書,涉一種單聲道多音頻流媒體文件的轉碼處理方法。
該發明專利主要應用於網達超高清文件編轉碼產品中,實現了特定音頻信號的快速效處理,提高了本產品對不同音視頻文件處理的適應能力。目前已在客户的視頻業務中得到了廣泛的使用。
上述發明專利的獲得不會對公司近期生產經營產生重大影響,但有利於進一步完善公司知識產權保護體系,充分發揮自主知識產權的技術優勢,促進技術創新,從而提升公司核心競爭力。敬請廣大投資者理性投資,注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.